ВОЗМОЖНОСТИ ПРИМЕНЕНИЯ МЕТОДА ГХ-МС...
НАУЧНОЕ ПРИБОРОСТРОЕНИЕ, 2010, том 20, № 4
47
Chromatogr. B. 1992. V. 579. P. 247–252.
68.
Lee K.J., Heo G.S., Kim N.J., Moon D.C. Analysis of
antiepileptic drugs in
human plasma using micellar
electrokinetic capillary chromatography // J. Chroma-
togr. B. 1992. V. 608. P. 243–250.
69.
Gupta R.N. Drug level monitoring: antidepressants // J.
Chromatogr. B. 1992. V. 576. P. 183–211.
70.
Bickeboeller-Friedrich J., Maurer H.H. Screening for
detection of new antidepressants, neuroleptics, hypnot-
ics, and their metabolites in urine by GC-MS devel-
oped using rat liver microsomes // Ther. Drug Monit.
2001. V. 23. P. 61–70.
71.
Maurer H., Pfleger K. Screening procedure for detec-
tion of antidepressants and their metabolites in urine
using a computerized gas chromatographic-mass spec-
trometric technique // J. Chromatogr. 1984. V. 305.
P. 309–323.
72.
Maurer H.H., Bickeboeller-Friedrich J. Screening pro-
cedure for detection of antidepressants of the selective
serotonin reuptake inhibitor type and their metabolites
in urine as part of a modified systematic toxicological
analysis procedure using gas chromatography-mass
spectrometry
//
J. Anal. Toxicol. 2000. V. 24. P. 340–
347.
73.
Maurer H., Pfleger K. Screening procedure for detect-
ing butyrophenone and bisfluorophenyl neuroleptics in
urine using a computerized
gas chromatographic-mass
spectrometric technique // J. Chromatogr. B. 1983.
V. 272. P. 75–85.
74.
Maurer H., Pfleger K. Screening procedure for detec-
tion of phenothiazine and analogous neuroleptics and
their metabolites in urine using a computerized gas
chromatographic-mass spectrometric technique
// J.
Chromatogr. B. 1984. V. 306. P. 125–145.
75.
Maurer H.H. Position of chromatographic techniques
in screening for detection of drugs or poisons in clini-
cal and forensic toxicology and/or doping control (re-
view) // Clin. Chem. Lab. Med. 2004. V. 42. P. 1310–
1324.
76.
Maurer H., Pfleger K. Identification and differentia-
tion of benzodiazepines and their metabolites in urine
by computerized gas chromatography-mass spectrome-
try // J. Chromatogr. 1987. V. 422. P. 85–101.
77.
Maurer H.H. Identification and differentiation of barbi-
turates, other sedative-hypnotics and their metabolites
in urine integrated in a general screening procedure us-
ing computerized gas chromatography-mass spectro-
metry // J. Chromatogr. 1990. V. 530, N 2. P. 307–326.
78.
Maurer H.H. Detection of anticonvulsants and their
metabolites in urine within a general unknown analysis
procedure using computerized
gas chromatography-
mass spectroscopy // Arch. Toxicol. 1990. V. 64.
P. 554–561.
79.
Maurer H., Pfleger K. Screening procedure for the de-
tection of antiparkinsonian drugs and their metabolites
in urine using a computerized gas chromatographic-
mass spectrometric technique // Fresenius' J. Anal.
Chem. 1985. V. 321, N 4. P. 363–370.
80.
Maurer H., Pfleger K. Identification of phenothiazine
antihistamines and their metabolites in urine // Arch.
Toxicol. 1988. V. 62. P. 185–191.
81.
Maurer H., Pfleger K. Screening procedure for the de-
tection of alkanolamine antihistamines and their meta-
bolites in urine using computerized gas chromatogra-
phy-mass spectrometry // J. Chromatogr. 1988. V. 428.
P. 43–60.
82.
Maurer H., Pfleger K. Toxicological detection of ethy-
lenediamine and piperazine antihistamines and their
metabolites in urine by computerized gas chromatogra-
phy-mass spectrometry // Fresenius' J. Anal. Chem.
1988. V. 331, N 7. P. 744–756.
83.
Maurer H., Pfleger K. Identification and differentiation
of alkylamine antihistamines and their metabolites in
urine by computerized gas chromatography-mass spec-
trometry // J. Chromatogr. B. 1988. V. 430. P. 31–41.
84.
Maurer H., Pfleger K. Screening procedure for the de-
tection of opioids, other potent analgesics and their me-
tabolites in urine using a computerized gas chromato-
graphic-mass spectrometric technique // Fresenius' J.
Anal. Chem. 1984. V. 317. P. 42–52.
85.
Maurer H., Pfleger K. Screening procedure for detect-
ing anti-inflammatory analgesics and their metabolites
in urine // Fresenius' J. Anal. Chem. 1983. V. 314, N 6.
P. 586–594.
86.
Maurer H.H. On the metabolism and the toxicological
analysis of methylenedioxyphenylalkylamine designer
drugs by gas chromatography-mass spectrometry //
Ther. Drug Monit. 1996. V. 18, N 4. P. 465–470.
87.
Kraemer T., Vernaleken I., Maurer H.H. Studies on the
metabolism and toxicological detection of the amphe-
tamine-like anorectic mefenorex in human urine by gas
chromatography-mass spectrometry and fluorescence
polarization immunoassay // J. Chromatogr. B. 1997.
V. 702. P. 93–102.
88.
Kraemer T., Theis G.A., Weber A.A., Maurer H.H. Stu-
dies on the metabolism and toxicological detection of
the amphetamine-like anorectic
fenproporex in human
urine by gas chromatography-mass spectrometry and
fluorescence polarization immunoassay (FPIA) // J.
Chromatogr. B. 2000. V. 738. P. 107–118.
89.
Kraemer T., Wennig R., Maurer H.H. The antispas-
modic mebeverine leads to positive amphetamine re-
sults with the fluorescence polarization immuno assay
(FPIA) — studies on the toxicological detection in
urine by GC-MS and FPIA // J. Anal. Toxicol. 2001.
V. 25. P. 1.
90.
Kraemer T., Roditis S.K., Peters F.T., Maurer H.H.
Amphetamine concentrations in human urine following
single-dose administration of the calcium antagonist
prenylamine — studies using FPIA and GC-MS // J.
Anal. Toxicol. 2003. V. 27. P. 68.
91.
Maurer H.H., Kraemer T. Toxicological detection of
selegiline and its metabolites in urine using
fluorescence polarization immunoassay (FPIA) and gas
chromatography-mass spectrometry (GC-MS) and dif-
ferentiation by enantioselective GC-MS of the intake
of selegiline from abuse of methamphetamine or am-
phetamine // Arch. Toxicol. 1992. V. 66, N 9. P. 675–
678.
92.
Maurer H.H., Kraemer T., Ledvinka O., Schmitt C.J.,
Достарыңызбен бөлісу: